Psoriasis: Scratching The Surface
A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 might be a useful therapeutic target in the treatment of psoriasis.
TITLE: Psoriasiform dermatitis is driven by interleukin-36-mediated dendritic cell-keratinocyte crosstalk
View this article at: http://www.jci.org/articles/view/63451?key=94c50375c771888cd255
Source: EurekAlert!, the online, global news service operated by AAAS, the science society
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Psoriasis: Scratching The Surface." Medical News Today. MediLexicon, Intl., 16 Oct. 2012. Web.
22 May. 2017. <http://www.medicalnewstoday.com/releases/251515.php>
Journal of Clinical Investigation. (2012, October 16). "Psoriasis: Scratching The Surface." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.